ENZO BIOCHEM INC. COMMON STOCK ($0.01 PAR VALUE)
1.0500
26-April-24 15:59:42
15 minutes delayed
Stocks
-0.0200
-1.87%
Today's range
1.0400 - 1.0700
ISIN
N/A
Source
NYSE
-
14 Oct 2022 07:30:00 By Nasdaq GlobeNewswire
-
10 Oct 2022 11:31:11 By Nasdaq GlobeNewswire
-
06 Oct 2022 08:00:02 By Nasdaq GlobeNewswire
-
26 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
Enzo Biochem to Launch Monkeypox Testing Services this Week
11 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
Enzo Biochem Appoints Matthew Kupferberg as General Counsel
03 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
09 Jun 2022 16:30:00 By Nasdaq GlobeNewswire
-
06 Jun 2022 08:30:00 By Nasdaq GlobeNewswire
-
02 Jun 2022 17:05:00 By Nasdaq GlobeNewswire
-
Enzo Biochem Announces New York State Department of Health Approval of HPV Molecular Diagnostic Test
19 Apr 2022 08:00:01 By Nasdaq GlobeNewswire
-
Enzo Biochem Reports Results of its Annual Meeting of Shareholders
12 Apr 2022 08:30:01 By Nasdaq GlobeNewswire
-
Enzo Biochem Adjourns Annual Meeting of Shareholders to Complete Vote on Proposal
06 Apr 2022 16:57:31 By Nasdaq GlobeNewswire
-
Enzo Biochem Adjourns Annual Meeting of Shareholders Until April 8, 2022
01 Apr 2022 08:00:00 By Nasdaq GlobeNewswire
-
Enzo Biochem Appoints David Bench and Kara Cannon to New Executive Management Positions
28 Mar 2022 16:17:04 By Nasdaq GlobeNewswire
-
Enzo Biochem Reports Second Quarter Fiscal 2022 Result and Provides Leadership and Corporate Updates
14 Mar 2022 16:10:00 By Nasdaq GlobeNewswire
-
Enzo Biochem to Present at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
10 Mar 2022 08:37:59 By Nasdaq GlobeNewswire
-
08 Mar 2022 08:29:03 By Nasdaq GlobeNewswire
-
Hamid Erfanian and Bradley Radoff Appointed to Enzo Biochem’s Board of Directors
03 Jan 2022 16:10:00 By Nasdaq GlobeNewswire
-
Enzo Biochem Reports First Quarter 2022 Financial Results and Provides Business Update
15 Dec 2021 16:05:00 By Nasdaq GlobeNewswire
-
02 Dec 2021 16:05:00 By Nasdaq GlobeNewswire